AFIB — Acutus Medical Cashflow Statement
0.000.00%
Last trade - 00:00
- $0.92m
- $15.59m
- $7.16m
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -97 | -102 | -118 | -39.6 | -81.7 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 40.7 | 19.7 | 15.4 | -51.9 | 22.1 |
Discontinued Operations | |||||
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.19 | -6.1 | -3.79 | 2.09 | -3.79 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -56 | -85.2 | -99.7 | -88.9 | -63.1 |
Capital Expenditures | -3.4 | -11.2 | -9.97 | -0.228 | -0.219 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -67 | -52.6 | 29 | 105 | 58.8 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -70.4 | -63.8 | 19.1 | 105 | 58.6 |
Financing Cash Flow Items | -2.33 | 0 | -0.804 | -1.8 | -0.77 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 126 | 164 | 79.6 | -11.6 | -2.66 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.173 | 15.8 | -1.16 | 7.13 | -5.15 |